Cipher Mining
CIFR
TeraWulf
WULF
Bitdeer Technologies
BTDR
Hut 8
HUT
Bakkt Holdings
BKKT
US Stock MarketDetailed Quotes
CALT Calliditas Therapeutics
- 40.000
- 0.0000.00%
Trading Sep 20 16:00 ET
1.08BMarket Cap-24.52P/E (TTM)
0.000High0.000Low0Volume0.000Open40.000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)27.02MShares43.00052wk High111.11P/B13.54MFloat Cap16.00052wk Low--Dividend TTM338.45KShs Float43.000Historical High--Div YieldTTM0.00%Amplitude10.820Historical Low--Avg Price1Lot Size
Calliditas Therapeutics Key Stats
EPS
According to the latest financial report of Calliditas Therapeutics, the latest earnings per share (TTM) for the company is -1.76. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: SEK
Quarterly
Loading...
FCF
Interested in knowing about Calliditas Therapeutics's free cash flow? The latest report shows it as -7.04M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: SEK
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Calliditas Therapeutics shows that the company's current ratio is 2.69, indicating healthy liquidity.
Currency: SEK
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Calliditas Therapeutics, the quick ratio is 2.59, indicating that the company can meet its short-term debt obligations.
Currency: SEK
Quarterly
Loading...
ROE
Want to learn more about the financial health of Calliditas Therapeutics? The latest ROE figure is -41.84%, indicating that the company has stable profitability.
Currency: SEK
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Calliditas Therapeutics, the total asset return on investment (ROA) is -2.76%.
Currency: SEK
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Calliditas Therapeutics's latest financial report to see how their gross margin is doing - currently at 90.45%.
Currency: SEK
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Calliditas Therapeutics, the net profit margin is -8.48%, which is a good sign for its profitability.
Currency: SEK
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.